EPH receptor A5
EPH receptor A5 (EphA5) is a protein that in humans is encoded by the EPHA5 gene. This protein belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands.
Function[edit]
EPH receptor A5 plays a critical role in the development of the nervous system. It is involved in the development of nerve connections in the brain, a process known as axon guidance. EphA5 interacts with cell-surface ephrin ligands, triggering signaling cascades that influence cell movement, shape, and attachment. This receptor is particularly important in the formation of the topographic maps in the brain, which are essential for spatial awareness and sensory processing.
In addition to its role in neural development, EphA5 has been studied for its involvement in cancer progression. Alterations in the expression of EphA5 have been observed in various types of cancer, suggesting that it may play a role in tumor growth and metastasis.
Structure[edit]
The structure of EPH receptor A5 includes an extracellular region, consisting of a globular domain, a cysteine-rich domain, followed by two fibronectin type III domains. This is connected to a single transmembrane segment and an intracellular region that contains the tyrosine kinase domain, a sterile alpha motif (SAM), and a PDZ-binding motif. The interaction of EphA5 with its ephrin ligands occurs through the extracellular domain, leading to receptor dimerization and activation of the kinase domain.
Clinical Significance[edit]
Research has indicated that EphA5 may serve as a potential therapeutic target in cancer treatment. Its role in tumor suppression and inhibition of metastasis makes it a candidate for targeted therapy. Additionally, due to its involvement in neural development, EphA5 is being studied in the context of neurodevelopmental disorders and neurodegenerative diseases. Understanding the signaling pathways mediated by EphA5 could lead to new therapeutic strategies for these conditions.
See Also[edit]
References[edit]
| Receptors | ||||||||
|---|---|---|---|---|---|---|---|---|
This receptor related article is a stub.
|
| Cell signaling / Signal transduction | ||||||||
|---|---|---|---|---|---|---|---|---|
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian